ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
about
The benefits and risks of testosterone replacement therapy: a reviewPhytotherapy: emerging therapeutic option in urologic diseaseTestosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practicesProtective effect of calretinin on testicular Leydig cells via the inhibition of apoptosis.Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men.Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.Recent trends in the treatment of testosterone deficiency syndrome.The diagnosis of late life hypogonadism.Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trialMale Andropause : A Myth or RealityMale sexual dysfunction in Asia.Effects of velvet antler polypeptide on sexual behavior and testosterone synthesis in aging male mice.Low serum testosterone increases mortality risk among male dialysis patients.Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.The effect of anthocyanin on the prostate in an andropause animal model: rapid prostatic cell death by apoptosis is partially prevented by anthocyanin supplementation.Clinical efficacy of Japanese traditional herbal medicine (Kampo) in patients with late-onset hypogonadism.Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late-Onset Hypogonadism Syndrome.Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study.Association between body fat distribution and androgen deficiency in middle-aged and elderly men in China.Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism.Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy.Lower urinary tract symptoms and erectile dysfunction associated with depression among Japanese patients with late-onset hypogonadism symptoms.Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.Correlation between the Japanese Aging Male Questionnaire (JAMQ) and Aging Male's Symptom (AMS) scale in Japanese male.The SET protein promotes androgen production in testicular Leydig cells.Clinical practice manual for late-onset hypogonadism syndrome.Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.Male infertility and androgen replacement therapy for subjects with bilateral testicular tumors.Testosterone therapy in the aging male
P2860
Q24658011-C969E056-9CBE-4F1C-99EC-A8B5D8013354Q26824548-6B219C23-7103-4A99-9450-736CDF6CFDB8Q28295533-F542088D-C998-418D-892F-37C5BB477B46Q33657488-B7BE1F97-D30E-4D37-89D4-FD08AFA33F8EQ36155429-76458231-8261-4794-9454-3DE9C94F0B93Q36371582-796E67D2-A4CB-4EAE-8CAB-951866EF3006Q36739886-0CD44BEF-0999-4131-BC6C-EC28B895315EQ36979941-2065F048-1349-43E0-BCC7-4EBD8B6DB9D8Q37011542-52B11B3E-400E-4BD8-ADC1-8985B6ADCDFDQ37037560-37D39406-6B48-4510-BEAF-D9F50717B99DQ37039346-2F99EEB7-1471-420D-9AFC-3A2EC6DA1568Q37085395-E29276C6-1E1A-42DC-8D0E-03AFF52D1630Q37113194-FD6E03D1-6D29-418A-BC3D-2AABDF669ACDQ37123233-506A85FA-CD88-4536-A0EB-166C8A6D8B84Q37340641-87BBB624-E745-4202-B638-4C70E98D9A93Q37875669-5AF121B8-56E8-46E5-BE4E-6C103D8FB42BQ38253709-4500FB36-E0FB-4F8C-9180-818C0C953102Q39291240-CAF9BE59-45B5-421E-B7D5-93C7920D83EFQ39857907-8BD038C1-3685-4465-A5C8-36AFE625A42BQ40215525-69D66F1F-7C0E-4329-AC9B-1B1A31232067Q42925108-0A93C66B-916B-440F-B66B-EAAC8D3799E1Q43842409-54F71345-4E7A-46E2-A6CB-9051DBD0F5C5Q46235754-4445C6AD-C038-40BA-98DD-16EEB9DB4FB6Q46526819-251BE7A4-21FF-4413-8CB6-127975DB2B1EQ47684542-706EB17A-DE80-4B24-8460-DC6E16826B67Q48038135-DF278B4F-5C9B-4C94-B7BA-A0C3A652C308Q48350407-901CB7DC-28FE-48C8-AFF5-4EB8BAF1BDD5Q48674083-2536F986-1F56-4608-BFC6-75C0F60CD46CQ48795981-D56D540A-0C28-4037-BF4E-52D43C4BC579Q50549102-32863DA8-E2E8-430D-BF8A-8CD253524B29Q50769670-B73EEF4A-0170-4F71-AF6D-08EF37C24A86Q51767184-E5681593-201C-4563-9C4B-A358474C5E2EQ51887248-FD67373E-9262-4A84-834F-9D2104C48D9EQ53162066-461F7DE4-26A3-4FB9-9DD9-CEBB5C10938BQ55182435-CB37A3DF-7F55-4AD1-A2DA-BA03D360EAC7Q58249332-C7742C96-90C1-457B-8105-9794108445F2
P2860
ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
ISA, ISSAM and EAU recommendat ...... ific background and rationale.
@ast
ISA, ISSAM and EAU recommendat ...... ific background and rationale.
@en
type
label
ISA, ISSAM and EAU recommendat ...... ific background and rationale.
@ast
ISA, ISSAM and EAU recommendat ...... ific background and rationale.
@en
prefLabel
ISA, ISSAM and EAU recommendat ...... ific background and rationale.
@ast
ISA, ISSAM and EAU recommendat ...... ific background and rationale.
@en
P2093
P2860
P1433
P1476
ISA, ISSAM and EAU recommendat ...... ific background and rationale.
@en
P2093
P2860
P356
10.1080/13685530500163416
P577
2005-06-01T00:00:00Z